Last $60.89 USD
Change Today -0.48 / -0.78%
Volume 1.8M
BMRN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henry J. Fuchs M.D., Ph.D.

Chief Medical Officer and Executive Vice President, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 4 different organizations across 7 different industries.

See Board Relationships
55$2,762,150
As of Fiscal Year 2012

Background*

Dr. Henry J. Fuchs, also known as Hank, M.D., Ph.D. has been Chief Medical Officer and Executive Vice President of BioMarin Pharmaceutical Inc. since March 2, 2009. Dr. Fuchs served as Senior Vice President of BioMarin Pharmaceutical Inc. since March 2, 2009. Dr. Fuchs served as the Chief Medical Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. from September 19, 2005 to December 1, 2008. He was responsible for research and development, including clinical ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

2001-N/A
Former Chief Operating Officer and Director
2001-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2006-N/A
Former Independent Director, Chairman of Scientific Committee and Member of Compensation Committee
2012-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2013-N/A
Former Director

Education*

BA
Harvard University
MD
George Washington University
PhD 1975
The University of Utah

Other Affiliations*

Annual Compensation*

Salary$466,400
Bonus$100,000
Total Annual Compensation$566,400

Stock Options*

Restricted Stock Awards$899,040
All Other Compensation$5,190
Exercised Options62,500
Exercised Options Value$1,745,559
Exercisable Options144,958
Exercisable Options Value$4,231,740
Unexercisable Options141,042
Unexercisable Options Value$2,939,880
Total Value of Options$8,917,179
Total Number of Options348,500

Total Compensation*

Total Annual Cash Compensation$854,510
Total Short Term Compensation$566,400
Other Long Term Compensation$904,230
Total Calculated Compensation$2,762,150
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $60.89 USD -0.48

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
John H. Johnson Executive Chairman, Chief Executive Officer and President
Dendreon Corp.
$736.4K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$2.4M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$722.2K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.